Case Study: Moderna cut time spent on data capture, search, and collection by 63% with Benchling
Key results
The challenge
With hundreds of scientists working across infectious diseases, cancer, and rare diseases, Moderna's research groups often worked in silos, and inconsistent, poorly structured data limited its ability to apply AI and machine learning. The company needed structured data, scalable and secure infrastructure, and unified tools.
The solution
Moderna expanded its use of Benchling as a unified, AI-ready platform across its research organization, standardizing naming schemes, schemas, templates, and workflows while using Benchling's developer platform to automate template generation and integrate proprietary machine-learning models.
The results, in context
Benchling reports that Moderna achieved a 63% reduction in time spent on data capture, search, and collection. Structured, centrally stored data improved cross-site collaboration and established AI/ML-ready foundations for the research organization.